ArticleCardiovascular diabetology2022

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs.

Dario Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.